Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BACH1 intronic transcript 2 (BACH1-IT2) is a non-coding RNA gene annotated within the intronic region of the human BACH1 gene. It does not encode a protein product and has not been characterized for biological function, disease association, or therapeutic relevance in the scientific literature or drug development resources[5]. BACH1-IT2 should not be confused with the BACH1 protein, which is a transcriptional regulator with important roles in oxidative stress, cell cycle, and cancer biology[1][3]. No aliases beyond gene database nomenclature are in use, and there is currently insufficient evidence to treat BACH1-IT2 as a structured molecular target for drug discovery, patient selection, or biomarker development. If you need structured information specifically for the BACH1 protein (a well-characterized transcription factor and regulator), that is distinct and should be handled separately, as BACH1-IT2 does not share its biological or therapeutic roles[1][3].
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BACH1 intronic transcript 2 (BACH1-IT2).